AFG
REGN icon

Atomi Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Atomi Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$782K Sell
1,253
-558
-31% -$380K 0.02% 567
2026
Q1 		$1.4M Buy
1,811
+135
+8% +$103K 0.04% 330
2025
Q4 		$1.29M Buy
1,676
+686
+69% +$466K 0.04% 330
2025
Q3 		$557K Buy
+990
New +$560K 0.02% 610
2025
Q2 		– Sell
-725
Closed -$460K – 1164
2025
Q1 		$460K Buy
725
+110
+18% +$75.7K 0.02% 572
2024
Q4 		$438K Buy
615
+40
+7% +$33.6K 0.02% 531
2024
Q3 		$605K Buy
575
+27
+5% +$30K 0.04% 385
2024
Q2 		$576K Buy
548
+166
+43% +$161K 0.04% 351
2024
Q1 		$368K Buy
382
+55
+17% +$52.3K 0.03% 453
2023
Q4 		$287K Buy
+327
New +$269K 0.04% 429

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Atomi Financial Group's REGN Position: Q2 2026 in Review

Atomi Financial Group reduced its Regeneron Pharmaceuticals (REGN) stake by 31% in Q2 2026, selling an estimated $380K and leaving 1,253 shares worth $782K. The position accounts for 0.02% of the portfolio, ranked #567.

Atomi Financial Group first reported a position in REGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.4M in Q1 2026. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Atomi Financial Group held 1,253 shares of Regeneron Pharmaceuticals worth $782K as of Q2 2026.
  • Atomi Financial Group sold 558 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $380K.
  • Regeneron Pharmaceuticals made up 0.02% of Atomi Financial Group's portfolio in Q2 2026, its #567 holding.
  • Atomi Financial Group first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Atomi Financial Group's Regeneron Pharmaceuticals position peaked at $1.4M in Q1 2026.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.